Bajaj Healthcare Ltd's API facility receives approval from TGA, Australia

Bajaj Healthcare Limited's API Manufacturing Site situated at Block No. 588, Savli-Karachiya Road, At & Post: Gothada, Tal. Savli, Dist: Vadodara, Gujarat has received approval from Therapeutic Goods Administration (TGA), Australia. The said site has already received approval from USFDA (U.S. Food and Drug Administration) and EU.

This is another major milestone achieved for the site and the Company in achieving the vision of becoming a Global supplier of APIs. This recognition by TGA of Site's manufacturing and compliance capabilities would pave the path for direct supplies of API to this stringent regulated territory as well as supplies to drug product manufacturers across the globe, who are supplying their finished product in the territory of Australia and New Zealand.

Post this recognition, the Company expects to attract more CDMO contracts from existing and new clients.

Source : Equity Bulls

Keywords

BajajHealthcare APIFacility Approval TGA Australia